Benjamin Blasco

1.9k total citations · 1 hit paper
15 papers, 707 citations indexed

About

Benjamin Blasco is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Benjamin Blasco has authored 15 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Benjamin Blasco's work include Malaria Research and Control (8 papers), Tuberculosis Research and Epidemiology (4 papers) and Mosquito-borne diseases and control (4 papers). Benjamin Blasco is often cited by papers focused on Malaria Research and Control (8 papers), Tuberculosis Research and Epidemiology (4 papers) and Mosquito-borne diseases and control (4 papers). Benjamin Blasco collaborates with scholars based in Switzerland, United States and United Kingdom. Benjamin Blasco's co-authors include Didier Leroy, David A. Fidock, Florence Pojer, Stewart T. Cole, Maëlle Duffey, Jeffrey M. Chen, Laura J. V. Piddock, Ruben C. Hartkoorn, Swapna Uplekar and Claudia Sala and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Reviews Drug Discovery.

In The Last Decade

Benjamin Blasco

14 papers receiving 698 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic

2017 344 citations Benjamin Blasco, Didier Leroy et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Blasco Switzerland	11	347	230	210	177	147	15	707
Santiago Ferrer Spain	21	281 0.8×	241 1.0×	382 1.8×	195 1.1×	140 1.0×	38	999
Dea Shahinas Canada	18	291 0.8×	320 1.4×	433 2.1×	267 1.5×	100 0.7×	26	996
Rachel L. Edwards United States	16	197 0.6×	89 0.4×	391 1.9×	79 0.4×	60 0.4×	22	741
Ekachai Jenwitheesuk Thailand	14	130 0.4×	280 1.2×	254 1.2×	97 0.5×	165 1.1×	24	728
Adelfa E. Serrano Puerto Rico	13	501 1.4×	119 0.5×	181 0.9×	80 0.5×	92 0.6×	27	828
Alfonso Mendoza Spain	14	144 0.4×	181 0.8×	323 1.5×	166 0.9×	45 0.3×	23	846
Abbas El Sahili Singapore	16	324 0.9×	243 1.1×	387 1.8×	126 0.7×	82 0.6×	29	854
Qin Cheng Australia	10	742 2.1×	183 0.8×	105 0.5×	147 0.8×	144 1.0×	16	845
Philipp P. Henrich United States	12	684 2.0×	124 0.5×	143 0.7×	86 0.5×	205 1.4×	19	824
Pornwaratt Niyomrattanakit Singapore	16	422 1.2×	809 3.5×	677 3.2×	410 2.3×	92 0.6×	20	1.5k

Countries citing papers authored by Benjamin Blasco

Since Specialization

Citations

This map shows the geographic impact of Benjamin Blasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Blasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Blasco more than expected).

Fields of papers citing papers by Benjamin Blasco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Blasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Blasco. The network helps show where Benjamin Blasco may publish in the future.

Co-authorship network of co-authors of Benjamin Blasco

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Blasco. A scholar is included among the top collaborators of Benjamin Blasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Blasco. Benjamin Blasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Brancucci, Nicolas M. B., Geert‐Jan van Gemert, Yu Xiao, et al.. (2025). An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs. Nature Communications. 16(1). 6884–6884. 1 indexed citations

Duffey, Maëlle, et al.. (2024). Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps. ACS Infectious Diseases. 10(5). 1458–1482. 22 indexed citations

Orena, Stephen, Patrick K. Tumwebaze, Oswald Byaruhanga, et al.. (2024). Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates. Antimicrobial Agents and Chemotherapy. 68(9). e0046624–e0046624.

Theuretzbacher, Ursula, Benjamin Blasco, Maëlle Duffey, & Laura J. V. Piddock. (2023). Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections. Nature Reviews Drug Discovery. 22(12). 957–975. 40 indexed citations

Mohring, Franziska, Donelly A. van Schalkwyk, Ryan C. Henrici, et al.. (2022). Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs. mBio. 13(5). e0117822–e0117822. 2 indexed citations

Duffey, Maëlle, Benjamin Blasco, Jeremy N. Burrows, et al.. (2021). Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends in Parasitology. 37(8). 709–721. 52 indexed citations

Schalkwyk, Donelly A. van, Benjamin Blasco, Jonathan Wee Kent Liew, et al.. (2019). Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum. International Journal for Parasitology Drugs and Drug Resistance. 9. 93–99. 20 indexed citations

Blasco, Benjamin, Didier Leroy, & David A. Fidock. (2017). Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nature Medicine. 23(8). 917–928. 344 indexed citations breakdown →

Scheurer, Christian, et al.. (2017). In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate. Malaria Journal. 16(1). 45–45. 25 indexed citations

10.

Schalkwyk, Donelly A. van, Robert W. Moon, Benjamin Blasco, & Colin J. Sutherland. (2017). Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents. Journal of Antimicrobial Chemotherapy. 72(11). 3051–3058. 28 indexed citations

11.

Bayih, Abebe Genetu, Anjan Debnath, Edward Mitre, et al.. (2017). Susceptibility Testing of Medically Important Parasites. Clinical Microbiology Reviews. 30(3). 647–669. 10 indexed citations

12.

Blasco, Benjamin, Aleksandre Japaridze, Marco Stenta, et al.. (2014). Functional Dissection of Intersubunit Interactions in the EspR Virulence Regulator of Mycobacterium tuberculosis. Journal of Bacteriology. 196(10). 1889–1900. 10 indexed citations

13.

Blasco, Benjamin, Jeffrey M. Chen, Ruben C. Hartkoorn, et al.. (2012). Virulence Regulator EspR of Mycobacterium tuberculosis Is a Nucleoid-Associated Protein. PLoS Pathogens. 8(3). e1002621–e1002621. 106 indexed citations

14.

Blasco, Benjamin, Marco Stenta, Livan Alonso‐Sarduy, et al.. (2011). Atypical DNA recognition mechanism used by the EspR virulence regulator of Mycobacterium tuberculosis. Molecular Microbiology. 82(1). 251–264. 23 indexed citations

15.

Chen, Jeffrey M., Florence Pojer, Benjamin Blasco, & Stewart T. Cole. (2010). Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium tuberculosis. Drug Discovery Today Disease Mechanisms. 7(1). e25–e31. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact